IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MUKARRAM A BAIG

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1073518569
CMS profile
93630
Location
HOUSTON, TX

General Payments · PY2018–2024

$5,441.56

  • Reported across 265 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$925.00

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Cardiovascular Disease TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $925.00 49

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $209.56 14
TACTILE SYSTEMS TECHNOLOGY INC $122.43 5
BOSTON SCIENTIFIC CORPORATION $116.23 4
Merck Sharp & Dohme Corporation $108.44 6
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $79.75 4
Amgen Inc. $68.05 4
E.R. Squibb & Sons, L.L.C. $67.61 4
Novo Nordisk AS $39.62 2
Janssen Pharmaceuticals, Inc $22.62 1
Lexicon Pharmaceuticals, Inc. $19.50 1
Kiniksa Pharmaceuticals International, plc $19.15 1
PFIZER INC. $19.03 1
AltaThera Pharmaceuticals LLC $16.94 1
AGEPHA Pharma FZ LLC $16.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,361.35 57
PY2019 $627.55 42
PY2020 $168.97 10
PY2021 $226.32 12
PY2022 $961.40 40
PY2023 $1,170.97 55
PY2024 $925.00 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AGEPHA Pharma FZ LLC $16.07 07/15/2024 Food and Beverage Undisputed 01/23/2026 1111015680 CMS
AltaThera Pharmaceuticals LLC $16.94 05/28/2024 Food and Beverage Undisputed 01/23/2026 1154344242 CMS
Amgen Inc. $19.69 03/05/2024 Food and Beverage Undisputed 01/23/2026 1115436035 CMS
Amgen Inc. $17.51 05/23/2024 Food and Beverage Undisputed 01/23/2026 1115436039 CMS
Amgen Inc. $16.78 06/21/2024 Food and Beverage Undisputed 01/23/2026 1115436043 CMS
Amgen Inc. $14.07 10/23/2024 Food and Beverage Undisputed 01/23/2026 1115436047 CMS
Boston Scientific Corporation $33.04 01/03/2024 Food and Beverage Undisputed 01/23/2026 1092622884 CMS
Boston Scientific Corporation $27.15 08/06/2024 Food and Beverage Undisputed 01/23/2026 1092622880 CMS
Boston Scientific Corporation $30.12 10/08/2024 Food and Beverage Undisputed 01/23/2026 1092622882 CMS
Boston Scientific Corporation $25.92 12/20/2024 Food and Beverage Undisputed 01/23/2026 1092622878 CMS
E.R. Squibb & Sons, L.L.C. $17.38 04/16/2024 Food and Beverage Undisputed 01/23/2026 1101762947 CMS
E.R. Squibb & Sons, L.L.C. $17.58 05/08/2024 Food and Beverage Undisputed 01/23/2026 1101762951 CMS
E.R. Squibb & Sons, L.L.C. $17.40 05/30/2024 Food and Beverage Undisputed 01/23/2026 1101762987 CMS
E.R. Squibb & Sons, L.L.C. $15.25 07/29/2024 Food and Beverage Undisputed 01/23/2026 1101762998 CMS
Janssen Pharmaceuticals, Inc $22.62 07/25/2024 Food and Beverage Undisputed 01/23/2026 1078203579 CMS
Kiniksa Pharmaceuticals International, plc $19.15 09/16/2024 Food and Beverage Undisputed 01/23/2026 1154890747 CMS
Lexicon Pharmaceuticals, Inc. $19.50 07/30/2024 Food and Beverage Undisputed 01/23/2026 1081712069 CMS
Merck Sharp & Dohme LLC $16.04 03/06/2024 Food and Beverage Undisputed 01/23/2026 1141562418 CMS
Merck Sharp & Dohme LLC $17.95 05/29/2024 Food and Beverage Undisputed 01/23/2026 1141911692 CMS
Merck Sharp & Dohme LLC $13.42 07/25/2024 Food and Beverage Undisputed 01/23/2026 1141562414 CMS
Merck Sharp & Dohme LLC $22.73 08/21/2024 Food and Beverage Undisputed 01/23/2026 1141562412 CMS
Merck Sharp & Dohme LLC $24.33 09/12/2024 Food and Beverage Undisputed 01/23/2026 1141824153 CMS
Merck Sharp & Dohme LLC $13.97 10/15/2024 Food and Beverage Undisputed 01/23/2026 1141562416 CMS
Novartis Pharmaceuticals Corporation $25.05 02/29/2024 Food and Beverage Undisputed 01/23/2026 1086708689 CMS
Novartis Pharmaceuticals Corporation $3.72 05/09/2024 Food and Beverage Undisputed 01/23/2026 1086708693 CMS
Novartis Pharmaceuticals Corporation $12.65 05/17/2024 Food and Beverage Undisputed 01/23/2026 1086708697 CMS
Novartis Pharmaceuticals Corporation $16.54 05/21/2024 Food and Beverage Undisputed 01/23/2026 1086708703 CMS
Novartis Pharmaceuticals Corporation $24.41 05/23/2024 Food and Beverage Undisputed 01/23/2026 1086708699 CMS
Novartis Pharmaceuticals Corporation $21.82 07/23/2024 Food and Beverage Undisputed 01/23/2026 1086708707 CMS
Novartis Pharmaceuticals Corporation $7.75 08/13/2024 Food and Beverage Undisputed 01/23/2026 1086708709 CMS
Novartis Pharmaceuticals Corporation $0.83 08/13/2024 Food and Beverage Undisputed 01/23/2026 1086708711 CMS
Novartis Pharmaceuticals Corporation $15.48 08/30/2024 Food and Beverage Undisputed 01/23/2026 1086708719 CMS
Novartis Pharmaceuticals Corporation $11.85 09/11/2024 Food and Beverage Undisputed 01/23/2026 1086708713 CMS
Novartis Pharmaceuticals Corporation $13.90 10/15/2024 Food and Beverage Undisputed 01/23/2026 1086708723 CMS
Novartis Pharmaceuticals Corporation $19.59 11/06/2024 Food and Beverage Undisputed 01/23/2026 1086708725 CMS
Novartis Pharmaceuticals Corporation $14.66 11/08/2024 Food and Beverage Undisputed 01/23/2026 1086708727 CMS
Novartis Pharmaceuticals Corporation $21.31 12/17/2024 Food and Beverage Undisputed 01/23/2026 1086708733 CMS
Novo Nordisk Inc $14.93 05/21/2024 Food and Beverage Undisputed 01/23/2026 1097661745 CMS
Novo Nordisk Inc $24.69 10/21/2024 Food and Beverage Undisputed 01/23/2026 1097741926 CMS
PFIZER INC. $19.03 12/02/2024 Food and Beverage Undisputed 01/23/2026 1131106572 CMS
Tactile Systems Technology Inc $28.34 04/11/2024 Food and Beverage Undisputed 01/23/2026 1082370161 CMS
Tactile Systems Technology Inc $18.24 07/23/2024 Food and Beverage Undisputed 01/23/2026 1082370169 CMS
Tactile Systems Technology Inc $20.95 09/06/2024 Food and Beverage Undisputed 01/23/2026 1082370167 CMS
Tactile Systems Technology Inc $29.95 10/22/2024 Food and Beverage Undisputed 01/23/2026 1082370163 CMS
Tactile Systems Technology Inc $24.95 11/14/2024 Food and Beverage Undisputed 01/23/2026 1082370165 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.52 01/08/2024 Food and Beverage Undisputed 01/23/2026 1080668587 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $18.83 03/04/2024 Food and Beverage Undisputed 01/23/2026 1080668589 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $20.48 05/14/2024 Food and Beverage Undisputed 01/23/2026 1080668591 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $21.92 09/03/2024 Food and Beverage Undisputed 01/23/2026 1080668593 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.